Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $84.4500 (-1.97%) ($84.1000 - $87.2850) on Wed. Oct. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.64% (three month average) | RSI | 24 | Latest Price | $84.4500(-1.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1% a day on average for past five trading days. | Weekly Trend | LGND declines -8.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.32% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-14%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.32% (StdDev 2.64%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $71.88(-14.88%) | Inflection Point | Yes | Resistance Level | $94.2 | 5 Day Moving Average | $85.12(-0.79%) | 10 Day Moving Average | $87.8(-3.82%) | 20 Day Moving Average | $94.2(-10.35%) | To recent high | -33.4% | To recent low | 5.1% | Market Cap | $1.357b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |